The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors. (Q38171958)

From Wikidata

Jump to navigation Jump to search

scientific article published on 18 December 2013

Language	Label	Description	Also known as
English	The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors.	scientific article published on 18 December 2013

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

The potential role of kynurenines in Alzheimer's disease: pathomechanism and therapeutic possibilities by influencing the glutamate receptors (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Alzheimer's disease

0 references

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

2

object named as

József Toldi

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Zsófia Majláth

1

object named as

Zsófia Majláth

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

publication date

18 December 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Journal of Neural Transmission

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

121

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

881-889

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Kynurenine metabolism in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine as an Intermediate in the Formation of Nicotinic Acid from Tryptophane by Neurospora

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine pathway measurements in Huntington's disease striatum: evidence for reduced formation of kynurenic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenic acid concentrations are reduced in Huntington's disease cerebral cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Protective effect of systemic L-kynurenine and probenecid administration on behavioural and morphological alterations induced by toxic soluble amyloid beta (25-35) in rat hippocampus.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The kynurenine pathway and inflammation in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Quinolinic acid effects on amino acid release from the rat cerebral cortex in vitro and in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Altered kynurenine metabolism correlates with infarct volume in stroke

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The endogenous agonist quinolinic acid and the non endogenous homoquinolinic acid discriminate between NMDAR2 receptor subunits

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Alzheimer disease as a vascular disorder: nosological evidence

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Paradox effects of kynurenines on LTP induction in the Wistar rat. An in vivo study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Cerebral microvascular pathology in aging and Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine metabolism predicts cognitive function in patients following cardiac bypass and thoracic surgery

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Blood?Brain Barrier Transport of Kynurenines: Implications for Brain Synthesis and Metabolism

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Behavioural studies with a newly developed neuroprotective KYNA-amide.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Neostriatal and cortical quinolinate levels are increased in early grade Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Astrocytic localization of kynurenine aminotransferase II in the rat brain visualized by immunocytochemistry

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine pathway metabolism in human astrocytes: a paradox for neuronal protection

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

A beta 1-42 induces production of quinolinic acid by human macrophages and microglia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Indoleamine 2,3 dioxygenase and quinolinic acid immunoreactivity in Alzheimer's disease hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Duration of antihypertensive drug use and risk of dementia: A prospective cohort study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

pH dependence, substrate specificity and inhibition of human kynurenine aminotransferase I.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Thermal stability, pH dependence and inhibition of four murine kynurenine aminotransferases

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Decreased serum and red blood cell kynurenic acid levels in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Quinolinic acid and kynurenine pathway metabolism in inflammatory and non-inflammatory neurological disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Focal cerebral ischemia in rats alters APP processing and expression of Abeta peptide degrading enzymes in the thalamus.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Is sporadic Alzheimer disease the brain type of non-insulin dependent diabetes mellitus? A challenging hypothesis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Glucose metabolism and insulin receptor signal transduction in Alzheimer disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Endogenous protectant kynurenic acid in amyotrophic lateral sclerosis

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

A diagnostic method for suspected Alzheimer's disease using H(2)15O positron emission tomography perfusion Z score

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Agonistic autoantibodies to the α(1) -adrenergic receptor and the β(2) -adrenergic receptor in Alzheimer's and vascular dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Antibodies to the α1-adrenergic receptor cause vascular impairments in rat brain as demonstrated by magnetic resonance angiography

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Age-specific and sex-specific prevalence and incidence of mild cognitive impairment, dementia, and Alzheimer dementia in blacks and whites: a report from the Einstein Aging Study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

A glycine site associated with N-methyl-D-aspartic acid receptors: characterization and identification of a new class of antagonists

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The neuroprotector kynurenic acid increases neuronal cell survival through neprilysin induction

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Vascular disease and dementias: paradigm shifts to drive research in new directions

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Decreased expression of kynurenine aminotransferase-I (KAT-I) in the substantia nigra of mice after 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) treatment

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Midlife blood pressure and the risk of hippocampal atrophy: the Honolulu Asia Aging Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenines and other novel therapeutic strategies in the treatment of dementia

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Direct evidence that release-stimulating alpha7* nicotinic cholinergic receptors are localized on human and rat brain glutamatergic axon terminals

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Oxaloacetate restores the long-term potentiation impaired in rat hippocampus CA1 region by 2-vessel occlusion

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Oxaloacetate decreases the infarct size and attenuates the reduction in evoked responses after photothrombotic focal ischemia in the rat cortex

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Effects of blood glutamate scavenging on cortical evoked potentials

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Role of kynurenines in the central and peripheral nervous systems

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Advances in the early detection of Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Cerebrovascular autoregulation is profoundly impaired in mice overexpressing amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Alterations in cerebral blood flow and glucose utilization in mice overexpressing the amyloid precursor protein

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Glutamate becomes neurotoxic via the N-methyl-D-aspartate receptor when intracellular energy levels are reduced

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine pathway abnormalities in Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Two kynurenine aminotransferases in human brain

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Diabetes mellitus and the risk of dementia: The Rotterdam Study.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Genetic and hormonal regulation of tryptophan kynurenine metabolism: implications for vascular cognitive impairment, major depressive disorder, and aging.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Memantine: a NMDA receptor antagonist that improves memory by restoration of homeostasis in the glutamatergic system--too little activation is bad, too much is even worse

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Increased brain concentrations of a neurotoxin, 3-hydroxykynurenine, in Huntington's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Type 2 diabetes, APOE gene, and the risk for dementia and related pathologies: The Honolulu-Asia Aging Study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

An iontophoretic investigation of the actions of convulsant kynurenines and their interaction with the endogenous excitant quinolinic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Midlife blood pressure and neuritic plaques, neurofibrillary tangles, and brain weight at death: the HAAS. Honolulu-Asia aging Study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenic acid has a dual action on AMPA receptor responses.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Insulin, insulin-degrading enzyme and amyloid-beta peptide in Alzheimer's disease: review and hypothesis.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The excitotoxin quinolinic acid induces tau phosphorylation in human neurons

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Quinolinic acid is a potent lipid peroxidant in rat brain homogenates

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The Janus-face kynurenic acid

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Blood pressure and risk of dementia: results from the Rotterdam study and the Gothenburg H-70 Study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Mitochondria, metabolic disturbances, oxidative stress and the kynurenine system, with focus on neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Alzheimer's disease: molecular understanding predicts amyloid-based therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Change in blood pressure and incident dementia: a 32-year prospective study

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Development and therapeutic potential of kynurenic acid and kynurenine derivatives for neuroprotection

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Quinolinic acid: a potent endogenous excitant at amino acid receptors in CNS

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Quinolinic acid stimulates synaptosomal glutamate release and inhibits glutamate uptake into astrocytes

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Diagnostic patterns of regional atrophy on MRI and regional cerebral blood flow change on SPECT in young onset patients with Alzheimer's disease, frontotemporal dementia and vascular dementia.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenines in the CNS: recent advances and new questions.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenic acid as a ligand for orphan G protein-coupled receptor GPR35

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Potential relevance of alpha(1)-adrenergic receptor autoantibodies in refractory hypertension

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Tryptophan degradation and immune activation in Alzheimer's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Increased neopterin production and tryptophan degradation in advanced Parkinson's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Mechanisms of neuronal degeneration in Alzheimer's disease

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Characterization of kynurenine aminotransferase III, a novel member of a phylogenetically conserved KAT family.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Neuroprotective effects of a novel kynurenic acid analogue in a transgenic mouse model of Huntington's disease.

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Mitochondrial disturbances, excitotoxicity, neuroinflammation and kynurenines: Novel therapeutic strategies for neurodegenerative disorders

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Kynurenine 3-monooxygenase inhibition in blood ameliorates neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

The Prevalence of Dementia in Europe: A Collaborative Study of 1980–1990 Findings

1 reference

https://api.crossref.org/works/10.1007%2FS00702-013-1135-5

21 January 2018

Traumatic brain injury-induced excitotoxicity assessed in a controlled cortical impact model

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The brain metabolite kynurenic acid inhibits alpha7 nicotinic receptor activity and increases non-alpha7 nicotinic receptor expression: physiopathological implications

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Sera from patients with type 2 diabetes contain agonistic autoantibodies against G protein-coupled receptors

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

SOD1 rescues cerebral endothelial dysfunction in mice overexpressing amyloid precursor protein

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Paradigm shift in NMDA receptor antagonist drug development: molecular mechanism of uncompetitive inhibition by memantine in the treatment of Alzheimer's disease and other neurologic disorders.

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synthesis and biological effects of some kynurenic acid analogs

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Degradation of tryptophan in neurodegenerative disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The effect of hormones and vitamin B6 on urinary excretion of metabolites of the kynurenine pathway

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Neuroprotection with a new kynurenic acid analog in the four-vessel occlusion model of ischemia

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Systemic administration of 4-chlorokynurenine prevents quinolinate neurotoxicity in the rat hippocampus

1 reference

https://pubmed.ncbi.nlm.nih.gov/24346138

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00702-013-1135-5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24346138%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38171958&oldid=2201357590"